Ticker
$REGN
1 catalyst touching REGN in the last 60 days, newest first, each with the price move that followed.
- 72
Regeneron, Sanofi expand antibody collaboration; $1B upfront, up to $7B milestones
Regeneron and Sanofi amended their antibody collaboration agreement to include four new Regeneron-invented antibodies targeting IL-13, IL-4, IL-4R, and a bispecific IL-4xIL-13 antibody. Sanofi will pay Regeneron $1.0 billion upfront and up to $7.0 billion in development, regulatory, and commercial milestones, with global profits on the New Licensed Products to be shared equally. This expands an existing partnership with significant near-term cash inflow and material long-term milestone and profit-sharing potential for a biotech company of Regeneron's scale.
REGN ▲SEC 8-K · 6 Oct 2026, 11:51 UTC
Information only. AURA does not give buy or sell recommendations.